$CURR On alert - CURE Pharmaceutical Closes $10 Mi
Post# of 103014
CURE Pharmaceutical Closes $10 Million Financing
- Funds will support the branding & product launch of Cure’s consumer products by newly acquired Sera Labs and the advancement of CURE’s clinical pharmaceutical pipeline -
CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes (the "Notes" . Axiom Capital Management, Inc. acted as the sole placement agent in the transaction.
https://finance.yahoo.com/news/cure-pharmaceu...00216.html